Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000242666 | SCV000301961 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Illumina Laboratory Services, |
RCV000377101 | SCV000355788 | likely benign | Chédiak-Higashi syndrome | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000377101 | SCV001723935 | benign | Chédiak-Higashi syndrome | 2025-02-03 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001651097 | SCV001868440 | benign | not provided | 2018-06-25 | criteria provided, single submitter | clinical testing | |
Unidad de Genómica Garrahan, |
RCV000242666 | SCV004232851 | benign | not specified | 2024-01-24 | criteria provided, single submitter | clinical testing | This variant is classified as Benign based on local population frequency. This variant was detected in 21% of patients studied by a panel of primary immunodeficiencies. Number of patients: 20. Only high quality variants are reported. |
Breakthrough Genomics, |
RCV001651097 | SCV005264415 | likely benign | not provided | criteria provided, single submitter | not provided |